The World Health Organization announced a 'temporary pause' on the inclusion of hydroxychloroquine in a global study on potential treatments for the disease.
The World Health Organization announced Monday a"temporary pause" on the inclusion of an anti-malarial drug, which President Donald Trump said he used to help stave off coronavirus, in a global study on potential treatments for the disease.
The trial's steering committee will use the pause to allow the Data Safety Monitoring Board to conduct a review and appraisal of"all evidence available globally" to"adequately evaluate the potential benefits and harms from this drug," Tedros said. "We want to use hydroxychloroquine if it is safe and efficacious, if it reduces mortality, reduces the length of hospitalization, without increasing the adverse events," said Dr. Soumya Swaminathan, WHO's chief scientist. Swaminathan said she expected the Solidarity trial's steering committee to review the Data Safety Monitoring Board's findings within the next two weeks.President Donald Trump thinks maybe. There's no data to support that.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Rebels destroy 150 schools, 22 health centres in DRC150 schools and 22 health centres are destroyed by rebels in DRC over the last two months – UN officials
続きを読む »
Sudan to establish police force to protect health workersSudan's transitional authorities say they are working to create a police force to protect health facilities and health workers.
続きを読む »
10 Dance Songs For Mental Health Awareness MonthIn honor of MentalHealthAwarenessMonth, here are 10 electronic tunes that bravely face the darkest parts of our minds, inviting us to find peace in musical escape.
続きを読む »